UC Davis School of Veterinary Medicine

School of Veterinary Medicine


topnavbar.gif International Laboratory of Molecular Biology (ILMB)
leftnavbar

Home
Mission
Faculty and Staff
Areas of Research & Training
Public Service
Curriculum Vitae / Honors / Awards
Teaching/Training/Technology Transfer
Research Accomplishments

Publications

Curriculum Vitae

Yilma Curriculum Vitae 8-03-07 (pdf file)
You will need the free acrobat reader from Adobe to view pdf files. Download Now


Education

University of California, Davis
B.S. 1968 Veterinary Science

University of California, Davis
D.V.M. 1970 Veterinary Medicine

University of California, Davis
Ph.D. 1977 Microbiology

Cornell University Medical College ---
1980 Medicine

Honors and Awards

National Academy of Sciences, Elected 2004
Fellow of American Academy of Microbiology, Elected 2004
Beecham Award for Research Excellence - 1986
Beecham Award for Research Excellence - 1988
The "1989 Ciba Geigy Award for Research in Animal Science" - 1990
School of Veterinary Medicine Alumni Achievement Award - 1991

Listed in "University of California Accomplishments" by Office of the President for University's 125th Anniversary Celebration. (Rinderpest invention cited.) - 1991

School of Veterinary Medicine Faculty Award for Research Excellence - 1991 Featured in August 1991 magazine Veterinary Forum on cover article entitled, "Who's Who in Biotechnology for the 1990's, The People behind the Progress” (one of 5 scientists)

Listed in Who's Who In The West, 1991 and 1992 Editions

School of Veterinary Medicine Faculty Award for Research Excellence - 1993

Listed in "University of California Davis' Financial Report 1993-94 - An Investment in Excellence". (Rinderpest vaccine cited.)

University of California Davis Distinguished Public Service Award for 1994-95 Featured in April 1995 issue of Wisconsin BioIssues, Biotechnology in Developing Countries

Listed in Who's Who in Medicine & Healthcare, June 95 issue

Listed in Who's Who in Medicine & Healthcare, first issue of 1996

Listed on the cover of Who's Who In Biotechnology for the 1990s

Featured as a role model in Visions (career guidance/life management workbook for African American males) California Department of Education, May 1996

The Walters Art Gallery (Committee Member), Baltimore, MD 21201

The Welcome Visiting Professor in the Microbiological Sciences, Louisiana State University, School of Veterinary Medicine, October 1998

University of Oklahoma International Alumnus Achievement Award, Nov 1999

University of California, School of Veterinary Medicine, Class of 2004 Outstanding

Faculty Lecturer Award, 2001-2002

University of California, Davis 2001-2002 Faculty Research Award, May 2002

Honorary and Professional Society Memberships (Past & Present)

California Veterinary Medical Association
American Veterinary Medical Association American Society for Microbiology
Honor Society of Phi Kappa
Phi Phi Zeta Society
American Association for the Advancement of Science
Association of American Veterinary Colleges
American Society for Virology
American Society of Tropical Veterinary Medicine
United States Animal Health Association
European Action on Global Life Sciences (EAGLES)


Publications

1. Yilma T, McVicar JW, Breese SS Jr: Prelytic release of foot and mouth disease virus in cytoplasmic blebs. J Gen Virol 41: 105 114, 1978.

2. Yilma T, Zee YC, Osebold JW: Immunofluorescence determination of the pathogenesis of infection with influenza virus in mice following exposure to aerosolized virus. J Infect Dis 139: 458 464, 1979.

3. Yilma T, Breese SS Jr: Morphogenesis of the assembly and release of bovine enterovirus. J Gen Virol 49: 225 230, 1980.

4. Yilma T,: Morphogenesis of vesiculation in foot and mouth disease. Am J Vet Res 41: 1537 1542, 1980.

5. Blackwell HJ, Yilma T: Localization of infectious foot and mouth disease virus in alveolar cells of the bovine mammary gland. Am J Vet Res 42: 770 773, 1980.

6. Yilma T, McGuire TC, Perryman LE: Preliminary characterization of equine interferons and their antiviral activities on bovine, ovine, and human cells. J Interferon Res 2: 363 370, 1982.

7. Yilma T, Perryman LE, McGuire TC: Deficiency of interferon q, but not interferon ß in Arabian foals with severe combined immunodeficiency. J Immunol 129: 931 933, 1982.

8. Yilma T: Sensitivity of ovine choroid plexus cells to human and other animal interferons. J Gen Virol 64: 2013 2016, 1983.

9. Yilma T, Breeze RG, Leib SR: Greater sensitivity of caprine synovial membrane cells to human interferon alpha than human or bovine cells. Am J Vet Res 45: 2094 2095, 1984.

10. Yilma T, Breeze RG, Ristow, S, Gorham J, Leib SR: The immune response of cattle and mice to the G glycoprotein of vesicular stomatitis virus. Immunobiology of Proteins and Peptides, 3:101-115, 1984.

11. Huang SA, Yilma T, Wu T Y: Correlation between virulence of vesicular stomatitis virus isolates and continued high titers during undiluted passage. Proc Int Conf Vesicular Stomatitis, Mexico City, D.F., Mexico, 1: 523 541, 1984.

12. Yilma T, Owens S, Adams DS: Preliminary characterization of a serum viral inhibitor in goats. Am J Vet Res 46: 2360 2362, 1985.

13. Davis WC, Yilma T, Perryman LE, McGuire TC: Perspectives on the application of monoclonal antibody and transfection technology in veterinary microbiology. Prog Vet Microbiol Immunol 1: 1 24, 1985.

14. Mackett M, Yilma T, Rose JK, Moss B: Vaccinia virus recombinants: Expression of VSV genes and protective immunization of mice and cattle. Science 227: 433 435, 1985.

15. Yilma T: Use of ovine and caprine cells to measure antiviral effects of interferon. Methods Enzymol 119: 551 558, 1985.

16. Yilma T: Induction of equine interferons. Methods Enzymol 119: 130 136, 1985.

17. Yilma T, Breeze RG, Ristow S, Gorham J, Leib SR: Immune responses of cattle and mice to the G glycoprotein of vesicular stomatitis virus. Adv Exp Med Biol 150: 101 115, 1985.

18. Yilma T, Breeze RG: New technology for prevention and control of infectious bovine respiratory diseases. Vet Clin North Am 1(2): 419 439, 1985.

19. Yilma T, Mackett M, Rose JK, Moss B: Vaccinia virus recombinants expressing vesicular stomatitis genes immunize mice and cattle. In: Quinnan GV ed. Vaccinia Viruses as Vectors for Vaccine Antigens. New York: Elsevier North Holland, pp. 187 200, 1985.

20. Jones L, Ristow S, Yilma T, Moss B: Accidental human vaccination with vaccinia virus expressing nucleoprotein gene. Nature 319: 543, 1986.

21. Huang AS, Wu T, Yilma T, Lanman G: Characterization of virulent isolates of vesicular stomatitis virus in relation to interference by defective particles. Microbial Pathogenesis 1: 205 215, 1986.

22. Workman T, Shen D, Woodard L, Yilma T: An enzyme linked immunoassay for the detection of bovine antibodies to vesicular stomatitis. Am J Vet Res 47: 1507 1512, 1986.

23. Yilma T, Breeze RG, Ristow S, Gorham J, Leib SR: A glycoprotein subunit vaccine for vesicular stomatitis. Proc World Assn for Buiatrics (XIV World Congr Dis Cattle) l: 408 413, l986.

24. Yilma T, Mackett M, Rose JK, Moss B: A vaccinia vector vaccine for vesicular stomatitis. Proc World Assn for Buiatrics (XIV World Congr Dis Cattle) l: 402 407, 1986.

25. Yilma T: Biotechnology for Livestock Production. In: Mahey B. ed. Virus Vector Vaccines. Food and Agriculture Organization of the United Nations, Rome, Italy. AGA: BIOT/86/32: 2 20, 1986.

26. Leid RW, Suquet CM, Grant RF, Tanigoshi L, Blanchard DB, Yilma T: Taeniaestatin, a cestode proteinase inhibitor with broad host regulatory activity. In: Agabian N, Goodman H, Noguiera N. Molecular Strategies of Parasitic Invasion. UCLA Symposium on Molecular and Cellular Biology, 42: 653 663. New York, Alan R. Liss, 1987.

27. Yilma T, Ristow S, Moss B, Jones L: A novel approach for the production of monoclonal antibodies using infectious vaccinia virus recombinants. Hybridoma 6: 329 335, 1987.

28. Yilma T, Anderson K., Brechling K, and Moss B: Expression of an adjuvant gene (IFN gamma) in infectious vaccinia virus recombinants. Vaccines, pp. 393 396, 1987.

29. Osburn BI, Yilma T: Animal Disease Diagnostics and Vaccines. ROC USA Agricultural Biotechnology Workshop, pp. 64 82, 1987.

30. Yilma T: Adjuvant genes for infectious virus recombinant vaccines: Use of lymphokines as adjuvants. Biotechnology U.S.A. 238 246, 1987.

31. Yilma T, Owens S, Adams SD: High levels of interferon in synovial fluid of retrovirus infected goats. J Interferon Res 8: 45 50, 1988.

32. Anderson P K, Fennie H, Yilma T: Enhancement of a secondary antibody response to vesicular stomatitis virus AG@ protein by interferon gamma treatment at primary immunization. J Immunol 40: 3599 3604, 1988.

33. Grubman M, Mebus C, Dale B, Yamanaka M, Yilma T: Analysis of the polypeptides synthesized in rinderpest virus infected cells. Virology 163: 261 267, 1988.

34. Ristow S, Leendersten L, Gorham J, Yilma T: Identification of a neutralizing epitope shared by bluetongue virus serotypes 2 and 13 . J. Virol. 62: 2502 2504, 1988.

35. Hsu D, Yamanaka M, Miller J, Dale B , Grubman M, Yilma T: Cloning of the fusion gene of rinderpest virus: comparative sequence analysis with other morbilliviruses. Virology 166: 149 153, 1988.

36. Yamanaka M, Hsu D, Dale B, Crisp T, Grubman M, Yilma T: Cloning and sequence analysis of the hemagglutinin gene of the virulent strain of rinderpest virus. Virology 166: 251 253, 1988.

37. Yilma T: Animal Biotechnology. In: The National Academy of Sciences & National Research Council: "Science & Technology for Development: Prospects Entering the 21st Century" pp. 38 40, 1988.

38. Yilma T., Hsu D., Jones L., Owens S., Grubman M., Mebus C., Yamanaka M., Dale B: Protection of cattle against rinderpest with vaccinia virus recombinants expressing the HA or F gene. Science 242: 1058 1061,1988.

39. Dale B, Brown R, Kloss, JM, Cordell B, Moore BO, Yilma T: Generation of vaccinia virus equine influenza A virus recombinants and their use as immunogens in horses. Fifth International Conference on Equine Infectious Diseases, 80-87, 1988.

40. Yilma T: Vaccinia virus as a vector for other antigens. Proc. U.S. Ani. Hlth. Assn 92: 94 99, 1988.

41. ole MoiYoi OK., Nayar A., Iams K., Musoke AJ, Yilma T: Molecular Aspects of Theileria parva and Approaches to Vaccine Development for Animals. In: Bloom BR, Cerami A eds. Biomedical Science and the Third World: Under the Volcano. Annals of the New York Academy of Sciences 569: 174 182, 1989.

42. Yilma T., Hsu D., Jones L., Owens S., Grubman M., Mebus C., Yamanaka M., Dale B: Expression of rinderpest genes in vaccinia virus Recombinants: Protective immunization of cattle. Vaccines, pp. 393 396, 1989.

43. Yilma T, Owens S, Fennie H, Anderson PK: Enhancement of primary and secondary immune responses by interferon gamma. Adv. Exp. Med. Bio. 251: 145 152, 1989.

44. Yilma T: Prospects for the total eradication of rinderpest. Vaccine 7: 484 485, 1989.

45. Yilma T: A recombinant vaccine for rinderpest. In: Mukherjee, T.K., ed. Proceedings of the FAO/UNDP Workshop on Biotechnology in Animal Production and Health in Asia and Latin America. Beijing, Oct 9 13, 1989.

46. Yilma T: Virus Vector Vaccinces. Biotechnology for Livestock Production, Chapter 33: 359-375, 1989.

47. Limo M, Yilma T: Molecular cloning of the rinderpest virus matrix gene: comparative sequence analysis with other paramyxoviruses. Virology 175: 323 327, 1990.

48. Yilma T: Accomplishments in recombinant vaccines. In Vasil I.K., ed. Biotechnology: Science, Education, and Commercialization. New York: Elsevier North Holland, pp 71 77, 1990.

49. McGraw TP, Vowles BR, Carlson JR, Luciw PA, Yilma T, Marx P, Haigwood N, Steimer SK, Gardner MB: Immune response of nonhuman primates infected with SIV and immunogenicity studies of lentivirus vaccine products. Vaccines, pp. 389 392, 1990.

50. Fox LK, Liggit HD, Corbeil LB, Yilma T: The effect of interferon gamma intramammary administration on mammary phagocyte function. J. Vet. Med. 37: 28 30, 1990.

51. Yilma T: A modern vaccine for an ancient plague: Rinderpest. Biotechnology 8: 1007 1009, 1990.

52. Chillakuru RA, Ryu DDY, Yilma T: Propagation of recombinant vaccinia virus in hela cells: Adsorption kinetics and replication in batch cultures. Biotechnol. Prog. 7: 85 92, 1991.

53. Yilma T: Genetically engineered viral vaccines. In: Mailu, A. M. et al., eds. Proceedings of the National Conference on Plant and Animal Biotechnology: Biotechnology in Kenya. Nairobi, pp. 59 66, 1991.

54. Limo MK, Ahmad S, Yilma T: Nucleic acid and monoclonal antibody probes in disease diagnosis. In: Mailu, A. M. et al, eds. Proceedings of the National Conference on Plant and Animal Biotechnology: Biotechnology in Kenya. Nairobi, pp. 103 111, 1991.

55. Giavedoni L, Jones L, Mebus C, Yilma T:A vaccinia virus double recombinant expressing F & H genes of rinderpest virus protects cattle against rinderpest and causes no pock lesions. Proc.Natl. Acad. Sci. U.S.A. 88: 8011 8015, 1991.

56. Yilma T: The role of biotechnology in tropical diseases. In Williams J, Kocan K, and Gibbs EP, Tropical Veterinary Medicine: Current Issues and Perspectives, Annals of the New York Academy of Sciences, 653: 1-6, June 16, 1991.

57. Yilma T: A vaccinia virus recombinant vaccine for rinderpest. World Animal Review (A Quarterly Journal of the FAO/UN on Animal Health, Production, and Products). 69: 2 6, 1991.

58. Gardner M, Yamamoto J, Marthas M, Miller C, Jennings M, Rosenthal A, Luciw P, Planelles V, Yilma T, Giavedoni L, Ahmad S, Steimer K, Haigwood N, Pedersen N: SIV and FIV vaccine studies at UC Davis: 1991 Update. Proceedings of the NCVDG, Marco Island, FL. October 15-19, 1991.

59. Yilma T, Jones L, Mebus C, Giavedoni L: A non pock forming vaccinia virus double recombinant expressing the F and H genes protects cattle against rinderpest. Proc. U.S. Ani. Hlth. Assn, 95th An Meeting, 50-58, 1992.

60. Planelles V, Giavedoni L, Marthas M, Ahmed S, Scandella C, Luciw P, Yilma T, Marx P, Lackner, A, Gardner M, Haigwood N: Vaccine studies with SIVmac1A11 recombinant GP130: lack of protection from SIVmac251 challenge. Vaccines, p. 123-129, 1992.

61. Haigwood N, Misher L, Chin SM, Blair M, Planelles V, Scandella C, Steimer K, Gardner M, Yilma T, Hirsch V, Johnson P: Characterization of group specific antibodies in primates: studies with SIV envelope in macaques. J. Med. Primatol., 21: 82-90, 1992.

62. Gardner MB, Yamamoto M, Marthas M, Miller C, Jennings M, Rosenthal A, Luciw P, Planelles V, Yilma T, Giavedoni L, Ahmad S, Steimer K, Haigwood N, Pedersen N: SIV and FIV Vaccine Studies at UC Davis: 1991 Update. AIDS Res.Hum.Retrov. 8:1495-1498, 1992.

63. Maclachlan NJ, Rossitto PV, Heidner HW, Iezzi LG, Yilma T, DeMaula CD, Osburn BI: Variation amongst the neutralizing epitopes of bluetongue viruses isolated in the United States in 1979 1981, Vet. Microbiology, 31: 303-316, 1992, Elseveir Science Publishers, 1992.

64. Yilma T: Recombinant Vaccines: Vaccinia Virus Vectored Vaccines. In, Osburn B, Castrucci G, Schore C: New and Emerging Infectious Diseases, Proceedings of the World Association of Veterinary Microbiologists, Immunologists and Specialists in Infectious Diseases (WAVMI), University of California, Davis, pgs. 181-187, Sept. 9-12, 1992.

65. Giavedoni L, Jones L, Gardner M, Gibson H, Ng C, Barr P, Yilma T: Vaccinia virus Recombinants Expressing Chimeric Proteins of Human Immunodeficiency Virus and Gamma-Interferon Are Attenuated for Nude Mice. Proc.Natl. Acad. Sci. U.S.A. 89: 3409 3413, 1992.

66. Yamanaka M, Dale B, Crisp T, Cordell, B, Grubman M, Yilma T: Sequence analysis and editing of the phosphoprotein (P) gene of rinderpest virus. Virology, 190: 553-556, 1992.

67. Yilma T. The Role of Biotechnology in Tropical Diseases. Ann N Y Acad Sci 653: 1-5, 1992.

68. Giavedoni L, Planelles V, Haigwood N, Ahmad S, Kluge JD, Marthas M, Gardner MB, Luciw P, Yilma T: Immune response of rhesus macaques to recombinant SIVgp130 does not protect from challenge infection. J. Virol, 67: 577-583, 1993.

69. Ahmad S, Bassiri M, Banerjee A, Yilma T: Immunological characterization of the VSVnucleocapsid (N) protein expressed by recombinant baculovirus in spodoptera exigua larva: Use in differential diagnosis between vaccinated and infected animals. Virology, 192: 207-216, 1993.

70. Bassiri M, Ahmad S, Giavedoni L, Jones L, Saliki J, Mebus C, Yilma T:Immunological Response ofMice and Cattle to Baculovirus-Expressed F and H proteins of rinderpest virus: Lack of protection in the presence of neutralizing antibody. J. Virol, 67: 1255-1261, 1993.

71. Ahmad S, Giavedoni L, El-Amad Z, Haigwood N, Kilpatrick J, Scandella C, Marthas M, Gardner M, Luciw P, Yilma T: Immune Response of Rhesus Macaques to Recombinant SIV gp160 Does Not Protect from Challenge Infection. Vaccines, p. 57-62, 1993.

72. Jones L, Giavedoni L, Saliki J, Brown C, Mebus C, Yilma T: Protection of goats against peste des petits ruminants with a vaccinia virus double recombinant expressing the F and H genes of rinderpest virus. Vaccine, 11:9, 961-964, 1993.

73. Yilma T, Giavedoni L, Saliki J, Brown C, Mebus C, Jones L: Protection of goats against peste des petits ruminants by a vaccinia virus double recombinant expressing the F and H genes of rinderpest virus. Proc. U.S. Ani. Hlth. Assn, 96th Annual Meeting, 184-189, Louisville, Kentucky, 1993.

74. Yilma T. Transfer of Technologies in Molecular Biology to Developing Countries. Recombinant Vaccines and Rapid Diagnostic Kits for Diseases in the Developing World. Ann N Y Acad Sci 700: 22-31, 1993.

75. Yilma, T: Vaccinia virus recombinant vaccines against rinderpest. In Volume of Recombinant Vaccines: New Vaccinology, Edouard Kurstak, Editor, 1994.

76. Yilma T Low risk of vaccinia virus recombinant (vRVFH) vaccine for rinderpest. New Scientist 744: 62, 1994.

77. Harrer E, Harrer T, Buchbinder S, Mann D.L., Feinberg M, Yilma T, Johnson R, and Walker B: HIV-1 specific cytotoxic T lymphocyte response in healthy, long-term nonprogressing seropositive persons. AIDS Res. Hum. Retrov, 10: 77-78, 1994.

78. Ismail T, Ahmad S, D'Souza-Ault M, Bassiri M, Saliki J, Mebus C, Yilma T: Cloning and expression of the nucleocapsid gene of virulent kabete o strain of rinderpest virus in baculovirus: use in differential diagnosis between vaccinated and infected animals. Virology 198: 138-147, 1994.

79. Yilma, T: Recombinant vaccines and rapid diagnostic kits: transfer of technologies to developing countries. In G. P. Talwar et al, eds., Recombinant and Synthetic Vaccines, Narcosa Publishing, Inc., 1-14, 1994.

80. Yilma, T: Transfer of technologies in molecular biology to developing countries - recombinant vaccines and rapid diagnostic kits for diseases in the developing world. In Biotechnology Research & Development Trends: Science Policy for Development, New York Academy of Sciences, 700: 22-31, 1994.

81. Ismail T, Ahmad S, Saliki J, Mebus C, Yilma T: Differential diagnosis between rinderpest-virus vaccinated and infected animals using the nucleocapsid protein expressed in baculovirus. Proc. U.S. Ani. Hlth. Assn, 97th Annual Meeting, Las Vegas, Nevada, pages 107-117, 1994.

82. Yilma T: Genetically engineered vaccines for animal viral diseases. J.Am.Vet.Med. Assn. 204:1606-15, 1994.

83. Ahmad S, Lohma B, Marthas M, Giavedoni L, El-Amad Z, Haigwood N, Scandella C, Gardner M, Luciw P, Yilma T: Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Res.Hum.Retrov, 10: 195-204, 1994.

84. Yilma T: Applications of recombinant vaccinia virus for veterinary vaccines. Recombinant Veterinary Vaccines, 82: 201-209, 1994.

85. Mitchell WM, Torres J, Johnson PR, Hirsch V, Yilma T, Gardner MB, Robinson WE Jr.: Antibodies to the putative SIV infection-enhancing domain diminish beneficial effects of an SIV gp160 vaccine in rhesus macaques. AIDS Res.Hum.Retrov , 9: 27-34, 1995.

86. Ismail T, Yamanaka M, Saliki J, El-Kholy A, Saliki J, Mebus C, and Yilma T: Cloning and expression of the nucleocapsid gene of peste des petits ruminants virus in baculovirus for use in serological diagnosis. Virology, 208: 776-778, 1995.

87. Yilma T: Vaccinia virus recombinant vaccines for rinderpest. Dev Biol Stand. Basel, Karger, 201-208, 1995.

88. Yilma T: Vaccine technology. Encyclopedia of Molecular Biology and Mol Medicine, 6: 945-947, 1995.

89. de Mattos CC, de Mattos CA, Maclachlan NJ, Giavedoni LD, Yilma T, Osburn BI. Phylogenetic Comparison of the S3 Gene of United States Prototype Strains of Bluetongue Virus with that of Field Isolates from California. J Virol 70(8): 5735-9, 1996.

90. Harrer T, Harrer E, Kalams S, Elbeik T, Staprans S.I., Feinberg M, Cao Y, Ho D, Yilma T, Caliendo A, Johnson R, Buchbinder S, and Walker B: Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV-1 infection. AIDS Res.Hum.Retrov, 12: 585-592, 1996.

91. Giavedoni L,Yilma T: Construction and characterization of replication-competent SIV vectors that express interferon-gamma. J. Virol., 70: 2247-2251, 1996.

92. Yilma T. Sustainable Animal Production in Developing Countries. The Forum Engleberg: Food & Water, A Question of Survival. Engleberg, Switzerland , p. 1-13, 1997.

93. Giavedoni L, Jones L, Ahmad S, Yilma T: Expression of gamma interferon by simian immunodeficiency virus decreases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques. J. Virol., 71:866-872, 1997.

94. Jones L, Tenorio E, Gorham J, Yilma T. Protective vaccination of ferrets against canine distemper with recom pox virus vaccines expressing the H or F genes of rinderpest virus. Ame. J Vet. Res. 58: 590-3, 1997.

95. Rickie WK, Wakenell PS, Ahmad S, Yilma T, Hirsh DC. Lack of protection against avian cholera by vaccination with recombinant P6-like protein from Pasteurella multocida. Avian Diseases 41: 972-976, 1997.

96. Yamanaka M, Yilma T. Altered plaque formation by recombinant vaccinia virus expressing SIV ?nef. J. Virol. 72: 5291-5295, 1998.

97. Araqdaib IE, Wilson WC, Shore CE, Mohammed MEH, Yilma T, Osburn BI. PCR detection of North America and Central African isolates of epizootic hemorrhagic disease virus (EHDV) based on genome segment 10 of EHDV Serotype 1. J Clin Micro 36: 2604-2608, 1998.

98. Hodges JF, Balasurya UBR, Ahmad S, TimoneyPJ, McCollum WH, Yilma T, Maclachlan NJ. Detection of Antibodies to equine arteritus virus by enzyme linked immonosorbant assays utilizing GL, M and N proteins expressed from recombinant baculoviruses. J. Virol. Meth. 76: 127-137,1998.

99. Patterson JB, Scheiflinger F, Manchester M, Yilma T, Oldstone MBA. Structural and functional studies of the measles virus hemagglutinin: Identification of a novel site required for CD46 interaction. Virology 256: 142-151, 1999.

100. Gauduin M-Cl, Clickman RL, Ahmad S. Yilma T, Johnson RP. Characterization of SIV specific CD4+ T helper proliferative responses in macaques immunized with live attenuated SIV. J. Med. Primatology. 28:233-241, 1999.

101. Gauduin M-Cl, Clickman RL, Ahmad S. Yilma T, Johnson RP. Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and ? chemokine production. Proc.Natl. Acad. Sci. U.S.A. 96: 14031-14036, 1999.

102. Jones L, Ahmad S, Verardi PH, Chan K, Simon V, Waddell D, and Yilma. T. Enhanced safety and efficacy of live attenuated SIV vaccines by prevaccination with recombinant vaccines. J. Med. Primatology, 29: 231-239, 2000.

103. Yilma TD, Ahmad S, Verardi PH, Aziz F, Diop M, Jones L, Egziabher B, Mabratu GY, Wamwayi H, Sarr J. A strategy for a successful end to the perpetual rinderpest eradication program: Recombinant vaccines and diagnostic kits for rinderpest. In: Jeggo, M, ed. Proceedings of the Third Research Co-ordination Meeting of the Co-ordinated Research Project on ARinderpest seromonitoring and surveillance in Africa using immunoassay technologies.@ Vienna, Austria, Oct16-20, 2000.

104. Ahmad S, Jones L, Yilma T: SIV expressing Interferon-G in rhesus macaques is a model for efficacious and safe live attenuated vaccines against AIDS. XIII International AIDS Conference, Monduzzi Editoire, 31-36, 2000.

105. Verardi, PH., L. Jones, F. Aziz, S. Ahmad, and Yilma. T. Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated in vivo without a concomitant reduction in immunogenicity. Journal of Virology 75: 11-18, 2001.

106. Roger F., Guebre Yesus M., Libeau G., Diallo A., Yigezu L.M., and Yilma. T. Detection of antibodies of rinderpest and peste des petits ruminants viruses (Paramyxoviridae, Morbillivirus) during a new epizootic disease in Ethiopian camels (Camelus dromedarius). Revue Med. Vet. 152: 265-268, 2001.

107. Yilma T. Biotechnology for Development: Human and Animal Health Perspectives. Scientific Forum, IAEA. 38-40, September 18-19, 2001.

108. Verardi P, Aziz F, Ahmad S, Jones L, Beyene B, Ngotho R, Wamwayi H, Gebre Yesus M, Gebre Egziabher B, Yilma T. Long-term sterilizing immunity to rinderpest in cattle vaccinated with a recombinant vaccinia virus expressing high levels of the fusion and hemagglutinin glycoproteins. J. Virology 76: 484-491, 2002.

109. Yilma T, Sarr J. Validation of an indirect enzyme-linked immunosorbent assay for the detection of antibodies against rinderpest virus in cattle. Inter-African Bureau for Animal Resources of the Organization of African Unity OAU-IBAR, September 2002.

110. Yilma T, Ahmad S, Jones L, Ngotho R, Wamwai H, Berhanu B, Mebratu G, Berhe G, Diop M, Sarr J, Aziz F, Verardi P. Inexpensive vaccines and rapid diagnostic kits tailor-made for the global eradication of rinderpest. In Vaccines for OIE List A and Emerging Animal Diseases. Developments in Biologicals . 114: 99-111, 2003.

111. Yilma T, Aziz F, Jones L, Ngotho R, Wamwai H, Beyene B, Yesus M, Eghiabher B, Diop M, Sarr J, Verardi P. Global eradication of rinderpest with recombinant vaccines and rapid diagnostic kits produced in Africa under the auspices of AU/IBAR. Verification of Rinderpest Freedom: FAO-EMPRES Technical Consultation on the Global Rinderpest Eradication Programme, 27-34, October 2002.

112. Yilma, T.D., L.A. Jones, and P.H. Verardi. Genetic engineering of vaccines. In R.A. Meyers (Ed.), Encyclopedia of Molecular Cell Biology and Molecular Medicine. WILEY-VCH, Weinheim, Germany, 2003.

113. Gauduin M-C, Kaur A, Ahmad S, Yilma T, Lifson JD, Johnson RP. Optimization of intracellular cytokine staining for the quantitation of antigen-specific CD4+ T cell responses in rhesus macaques. J. Immunol. Methods. 288: 61-79, 2004.

114. Legrand F, Verardi P, Jones L, Chan K, Peng Y, Yilma T. Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes. J. Virology. 78: 2770-2779, March 2004.

115. Legrand FA, Verardi PH, Chan KS, Peng Y, Jones LA, Yilma T. Vaccinia viruses with a serpin gene deletion and expressing IFN- ?-induce potent immune responses without detectable replication in vivo. Proc. Natl. Acad. Sci. U.S.A. 102: 2940-2945, 2004.

116. Chan KC, Verardi PH, Legrand FA, Yilma T. Nef from pathogenic simian immunodeficiency virus is a negative factor for vaccinia virus. Proc. Natl. Acad. Sci. U.S.A. 102: 8734-8739, 2005.

117. Peng Y, Lin FC, Verardi PH, Jones LA, McChesney MB, Yilma TD. Pseudotyped Single-Cycle Simian Immunodeficiency Viruses Expressing Gamma Interferon Augment T-Cell Priming Responses In Vitro. J. Virology. 81: 2187-2195, March 2007.